|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/16/2024 |
$58.04 |
$58.74 |
$57.14 |
$57.96 |
1.18M | 04/17/2024 |
$58.34 |
$58.47 |
$55.52 |
$55.56 |
1.40M | 04/18/2024 |
$55.86 |
$58.03 |
$55.25 |
$56.16 |
1.75M | 04/19/2024 |
$56.16 |
$57.50 |
$54.27 |
$55.05 |
1.77M | 04/22/2024 |
$55.40 |
$56.93 |
$54.37 |
$55.66 |
1.04M |
|
CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells. | |
|
CRISPR Therapeutics AG (CRSP) has the following price history information. Looking back at CRSP historical stock prices for the last five trading days, on April 16, 2024, CRSP opened at $58.04, traded as high as $58.74 and as low as $57.14, and closed at $57.96. Trading volume was a total of 1.18M shares. On April 17, 2024, CRSP opened at $58.34, traded as high as $58.47 and as low as $55.52, and closed at $55.56. Trading volume was a total of 1.40M shares. On April 18, 2024, CRSP opened at $55.86, traded as high as $58.03 and as low as $55.25, and closed at $56.16. Trading volume was a total of 1.75M shares. On April 19, 2024, CRSP opened at $56.16, traded as high as $57.50 and as low as $54.27, and closed at $55.05. Trading volume was a total of 1.77M shares. On April 22, 2024, CRSP opened at $55.40, traded as high as $56.93 and as low as $54.37, and closed at $55.66. Trading volume was a total of 1.04M shares.
CRSP Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into CRISPR Therapeutics AG shares, starting with a $10,000 purchase of CRSP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/20/2016 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$13.94 |
|
End price/share: |
$55.66 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
299.28% |
|
Average Annual Total Return: |
20.25% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$39,939.82 |
|
Years: |
7.51 |
|
|
|
Date |
Close |
04/16/2024 | $57.96 | 04/17/2024 | $55.56 | 04/18/2024 | $56.16 | 04/19/2024 | $55.05 | 04/22/2024 | $55.66 |
|
|